190 related articles for article (PubMed ID: 19838704)
1. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
Van Laere K; Varrone A; Booij J; Vander Borght T; Nobili F; Kapucu OL; Walker Z; Någren K; Tatsch K; Darcourt J
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):434-42. PubMed ID: 19838704
[TBL] [Abstract][Full Text] [Related]
2. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
Darcourt J; Booij J; Tatsch K; Varrone A; Vander Borght T; Kapucu OL; Någren K; Nobili F; Walker Z; Van Laere K
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):443-50. PubMed ID: 19838702
[TBL] [Abstract][Full Text] [Related]
3. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.
Kapucu OL; Nobili F; Varrone A; Booij J; Vander Borght T; Någren K; Darcourt J; Tatsch K; Van Laere KJ
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2093-102. PubMed ID: 19838703
[TBL] [Abstract][Full Text] [Related]
4. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.
Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky LS; Pupi A;
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP23-9. PubMed ID: 12436495
[No Abstract] [Full Text] [Related]
5. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
Varrone A; Asenbaum S; Vander Borght T; Booij J; Nobili F; Någren K; Darcourt J; Kapucu OL; Tatsch K; Bartenstein P; Van Laere K;
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2103-10. PubMed ID: 19838705
[TBL] [Abstract][Full Text] [Related]
6. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.
Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky LS; Pupi A;
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP30-5. PubMed ID: 12436496
[No Abstract] [Full Text] [Related]
7. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D; Timmers HJ; Hindié E; Guillet BA; Neumann HP; Walz MK; Opocher G; de Herder WW; Boedeker CC; de Krijger RR; Chiti A; Al-Nahhas A; Pacak K; Rubello D;
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1977-95. PubMed ID: 22926712
[TBL] [Abstract][Full Text] [Related]
8. EANM procedure guidelines for brain PET imaging using [
Guedj E; Varrone A; Boellaard R; Albert NL; Barthel H; van Berckel B; Brendel M; Cecchin D; Ekmekcioglu O; Garibotto V; Lammertsma AA; Law I; Peñuelas I; Semah F; Traub-Weidinger T; van de Giessen E; Van Weehaeghe D; Morbelli S
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):632-651. PubMed ID: 34882261
[TBL] [Abstract][Full Text] [Related]
9. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
[TBL] [Abstract][Full Text] [Related]
10. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D; Hicks RJ; Hindié E; Guillet BA; Avram A; Ghedini P; Timmers HJ; Scott AT; Elojeimy S; Rubello D; Virgolini IJ; Fanti S; Balogova S; Pandit-Taskar N; Pacak K
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2112-2137. PubMed ID: 31254038
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine.
Vander Borght T; Laloux P; Maes A; Salmon E; Goethals I; Goldman S;
Acta Neurol Belg; 2001 Dec; 101(4):196-209. PubMed ID: 11851026
[TBL] [Abstract][Full Text] [Related]
12. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
Laruelle M
J Cereb Blood Flow Metab; 2000 Mar; 20(3):423-51. PubMed ID: 10724107
[TBL] [Abstract][Full Text] [Related]
13. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
14. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.
Morbelli S; Esposito G; Arbizu J; Barthel H; Boellaard R; Bohnen NI; Brooks DJ; Darcourt J; Dickson JC; Douglas D; Drzezga A; Dubroff J; Ekmekcioglu O; Garibotto V; Herscovitch P; Kuo P; Lammertsma A; Pappata S; Peñuelas I; Seibyl J; Semah F; Tossici-Bolt L; Van de Giessen E; Van Laere K; Varrone A; Wanner M; Zubal G; Law I
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1885-1912. PubMed ID: 32388612
[TBL] [Abstract][Full Text] [Related]
15. Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
Acton PD; Hou C; Kung MP; Plössl K; Keeney CL; Kung HF
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1507-15. PubMed ID: 12537007
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography.
Bergström KA; Yu M; Kuikka JT; Akerman KK; Hiltunen J; Lehtonen J; Halldin C; Tiihonen J
Eur J Nucl Med; 2000 Feb; 27(2):206-8. PubMed ID: 10755727
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.
Gerasimou GP; Aggelopoulou TC; Costa DC; Gotzamani-Psarrakou A
Nucl Med Rev Cent East Eur; 2006; 9(2):147-53. PubMed ID: 17304479
[TBL] [Abstract][Full Text] [Related]
18. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain.
Yamamoto Y; Takahata K; Kubota M; Takano H; Takeuchi H; Kimura Y; Sano Y; Kurose S; Ito H; Mimura M; Higuchi M
Neuroimage; 2021 Feb; 226():117543. PubMed ID: 33186713
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
Farde L; Hall H
Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
[TBL] [Abstract][Full Text] [Related]
20. Guidelines to PET measurements of the target occupancy in the brain for drug development.
Takano A; Varrone A; Gulyás B; Salvadori P; Gee A; Windhorst A; Vercouillie J; Bormans G; Lammertsma AA; Halldin C
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2255-2262. PubMed ID: 27514528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
